Bruce Booth is a Partner at Atlas Venture, where he invests in early-stage biotech therapeutics across the United States (notably Greater Boston) and Germany. He backs companies from Seed through Series C and has invested in Sionna Therapeutics, Nimbus Therapeutics, Matchpoint Therapeutics, Arkuda Therapeutics, and HotSpot Therapeutics. He serves on the boards of Kymera Therapeutics, Nimbus Therapeutics, Arkuda Therapeutics, HotSpot Therapeutics, and Sionna Therapeutics. He is based in Wellesley, Massachusetts, and studied at the University of Oxford. His firm’s most recent fundraise was in September 2025.
Bruce Booth, Partner @ Atlas. Profile with intro opportunities and ranking information.